Skip to main content
Erschienen in: Tumor Biology 5/2016

28.11.2015 | Original Article

The alkyllysophospholipid edelfosine enhances TRAIL-mediated apoptosis in gastric cancer cells through death receptor 5 and the mitochondrial pathway

verfasst von: Sung-Chul Lim, Keshab Raj Parajuli, Song Iy Han

Erschienen in: Tumor Biology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

The ether phospholipid edelfosine is the prototype of a group of synthetic antitumor alkyllysophospholipid (ALP) compounds that exert pro-apoptotic effects in various types of cancer cells through cell type-dependent mechanisms. In this study, we examined the antitumor effect of edelfosine in human gastric cancer cells. Edelfosine decreased cell viability and induced autophagic death at a moderate concentration (~30 μM), whereas it induced apoptotic cell death at concentrations over 30 μM. Interestingly, low concentrations of edelfosine (5–10 μM) effectively enhanced recombinant human tumor necrosis factor (TNF)-related apoptosis-inducing ligand (rhTRAIL/TNFSF10)-induced apoptosis and clonogenicity in gastric cancer cells, including TRAIL-resistant AGS cells. Edelfosine upregulated the protein level of death receptor 5 (DR5/TNFRSF10B) and/or increased DR5 upregulation in lipid rafts. In addition, edelfosine-mediated rhTRAIL sensitization was regulated by the DR5 pathway. Edelfosine also activated p38MAPK (MAPK14), and edelfosine-mediated rhTRAIL sensitization was partially regulated by a p38-mediated decrease in mitochondrial membrane potential. This study suggests a novel therapeutic strategy targeting gastric cancer cells by using the combination of edelfosine and TRAIL.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29.CrossRefPubMed Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29.CrossRefPubMed
2.
Zurück zum Zitat Gura T. How trail kills cancer cells, but not normal cells. Science (New York, NY). 1997;277:768.CrossRef Gura T. How trail kills cancer cells, but not normal cells. Science (New York, NY). 1997;277:768.CrossRef
3.
Zurück zum Zitat Baker SJ, Reddy EP. Modulation of life and death by the tnf receptor superfamily. Oncogene. 1998;17:3261–70.CrossRefPubMed Baker SJ, Reddy EP. Modulation of life and death by the tnf receptor superfamily. Oncogene. 1998;17:3261–70.CrossRefPubMed
4.
Zurück zum Zitat Scaffidi C, Medema JP, Krammer PH, Peter ME. Flice is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem. 1997;272:26953–8.CrossRefPubMed Scaffidi C, Medema JP, Krammer PH, Peter ME. Flice is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem. 1997;272:26953–8.CrossRefPubMed
5.
Zurück zum Zitat Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, et al. Trail receptor-2 signals apoptosis through fadd and caspase-8. Nat Cell Biol. 2000;2:241–3.CrossRefPubMed Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, et al. Trail receptor-2 signals apoptosis through fadd and caspase-8. Nat Cell Biol. 2000;2:241–3.CrossRefPubMed
6.
Zurück zum Zitat Li H, Zhu H, Xu CJ, Yuan J. Cleavage of bid by caspase 8 mediates the mitochondrial damage in the fas pathway of apoptosis. Cell. 1998;94:491–501.CrossRefPubMed Li H, Zhu H, Xu CJ, Yuan J. Cleavage of bid by caspase 8 mediates the mitochondrial damage in the fas pathway of apoptosis. Cell. 1998;94:491–501.CrossRefPubMed
7.
Zurück zum Zitat Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer. 2002;2:420–30.CrossRefPubMed Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer. 2002;2:420–30.CrossRefPubMed
9.
Zurück zum Zitat Jin CY, Park C, Cheong J, Choi BT, Lee TH, Lee JD, et al. Genistein sensitizes trail-resistant human gastric adenocarcinoma ags cells through activation of caspase-3. Cancer Lett. 2007;257:56–64.CrossRefPubMed Jin CY, Park C, Cheong J, Choi BT, Lee TH, Lee JD, et al. Genistein sensitizes trail-resistant human gastric adenocarcinoma ags cells through activation of caspase-3. Cancer Lett. 2007;257:56–64.CrossRefPubMed
10.
Zurück zum Zitat Prasad S, Yadav VR, Kannappan R, Aggarwal BB. Ursolic acid, a pentacyclin triterpene, potentiates trail-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and jnk. J Biol Chem. 2011;286:5546–57.CrossRefPubMed Prasad S, Yadav VR, Kannappan R, Aggarwal BB. Ursolic acid, a pentacyclin triterpene, potentiates trail-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and jnk. J Biol Chem. 2011;286:5546–57.CrossRefPubMed
11.
Zurück zum Zitat Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, Sarfaraz S, et al. Green tea polyphenol egcg sensitizes human prostate carcinoma lncap cells to trail-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene. 2008;27:2055–63.CrossRefPubMed Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, Sarfaraz S, et al. Green tea polyphenol egcg sensitizes human prostate carcinoma lncap cells to trail-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene. 2008;27:2055–63.CrossRefPubMed
12.
Zurück zum Zitat Szliszka E, Krol W. The role of dietary polyphenols in tumor necrosis factor-related apoptosis inducing ligand (trail)-induced apoptosis for cancer chemoprevention. Eur J Cancer Prev : Off J Eur Cancer Prev Org. 2011;20:63–9.CrossRef Szliszka E, Krol W. The role of dietary polyphenols in tumor necrosis factor-related apoptosis inducing ligand (trail)-induced apoptosis for cancer chemoprevention. Eur J Cancer Prev : Off J Eur Cancer Prev Org. 2011;20:63–9.CrossRef
13.
Zurück zum Zitat Gajate C, Mollinedo F. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid et-18-och(3) (edelfosine), a proapoptotic agent in tumor cells. Curr Drug Metab. 2002;3:491–525.CrossRefPubMed Gajate C, Mollinedo F. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid et-18-och(3) (edelfosine), a proapoptotic agent in tumor cells. Curr Drug Metab. 2002;3:491–525.CrossRefPubMed
14.
Zurück zum Zitat van Blitterswijk WJ, Verheij M. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects. Curr Pharm Des. 2008;14:2061–74.CrossRefPubMed van Blitterswijk WJ, Verheij M. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects. Curr Pharm Des. 2008;14:2061–74.CrossRefPubMed
15.
Zurück zum Zitat Mollinedo F, Martinez-Dalmau R, Modolell M. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid et-18-och3. Biochem Biophys Res Commun. 1993;192:603–9.CrossRefPubMed Mollinedo F, Martinez-Dalmau R, Modolell M. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid et-18-och3. Biochem Biophys Res Commun. 1993;192:603–9.CrossRefPubMed
16.
Zurück zum Zitat Mollinedo F, Fernandez-Luna JL, Gajate C, Martin-Martin B, Benito A, Martinez-Dalmau R, et al. Selective induction of apoptosis in cancer cells by the ether lipid et-18-och3 (edelfosine): molecular structure requirements, cellular uptake, and protection by bcl-2 and bcl-x(l). Cancer Res. 1997;57:1320–8.PubMed Mollinedo F, Fernandez-Luna JL, Gajate C, Martin-Martin B, Benito A, Martinez-Dalmau R, et al. Selective induction of apoptosis in cancer cells by the ether lipid et-18-och3 (edelfosine): molecular structure requirements, cellular uptake, and protection by bcl-2 and bcl-x(l). Cancer Res. 1997;57:1320–8.PubMed
17.
Zurück zum Zitat Gajate C, Mollinedo F. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine. Anti Cancer Agents Med Chem. 2014;14:509–27.CrossRef Gajate C, Mollinedo F. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine. Anti Cancer Agents Med Chem. 2014;14:509–27.CrossRef
18.
Zurück zum Zitat Diomede L, Colotta F, Piovani B, Re F, Modest EJ, Salmona M. Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action. Int J Cancer. 1993;53:124–30.CrossRefPubMed Diomede L, Colotta F, Piovani B, Re F, Modest EJ, Salmona M. Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action. Int J Cancer. 1993;53:124–30.CrossRefPubMed
19.
Zurück zum Zitat Leonard R, Hardy J, van Tienhoven G, Houston S, Simmonds P, David M, et al. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J Clin Oncol. 2001;19:4150–9.CrossRefPubMed Leonard R, Hardy J, van Tienhoven G, Houston S, Simmonds P, David M, et al. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J Clin Oncol. 2001;19:4150–9.CrossRefPubMed
20.
Zurück zum Zitat Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, Campanero MA, et al. Lipid raft-targeted therapy in multiple myeloma. Oncogene. 2010;29:3748–57.CrossRefPubMed Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, Campanero MA, et al. Lipid raft-targeted therapy in multiple myeloma. Oncogene. 2010;29:3748–57.CrossRefPubMed
21.
Zurück zum Zitat Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, de Frias M, et al. In vitro and in vivo selective antitumor activity of edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts. Clin Cancer Res. 2010;16:2046–54.CrossRefPubMed Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, de Frias M, et al. In vitro and in vivo selective antitumor activity of edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts. Clin Cancer Res. 2010;16:2046–54.CrossRefPubMed
22.
Zurück zum Zitat Gajate C, Matos-da-Silva M, Dakir el H, Fonteriz RI, Alvarez J, Mollinedo F. Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum. Oncogene. 2012;31:2627–39.CrossRefPubMed Gajate C, Matos-da-Silva M, Dakir el H, Fonteriz RI, Alvarez J, Mollinedo F. Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum. Oncogene. 2012;31:2627–39.CrossRefPubMed
23.
Zurück zum Zitat Jendrossek V, Handrick R. Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisers. Curr Med Chem. 2003;3:343–53. Jendrossek V, Handrick R. Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisers. Curr Med Chem. 2003;3:343–53.
24.
Zurück zum Zitat van der Luit AH, Vink SR, Klarenbeek JB, Perrissoud D, Solary E, Verheij M, et al. A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells. Mol Cancer Ther. 2007;6:2337–45.CrossRefPubMed van der Luit AH, Vink SR, Klarenbeek JB, Perrissoud D, Solary E, Verheij M, et al. A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells. Mol Cancer Ther. 2007;6:2337–45.CrossRefPubMed
25.
Zurück zum Zitat Gajate C, Del Canto-Janez E, Acuna AU, Amat-Guerri F, Geijo E, Santos-Beneit AM, et al. Intracellular triggering of fas aggregation and recruitment of apoptotic molecules into fas-enriched rafts in selective tumor cell apoptosis. J Exp Med. 2004;200:353–65.CrossRefPubMedPubMedCentral Gajate C, Del Canto-Janez E, Acuna AU, Amat-Guerri F, Geijo E, Santos-Beneit AM, et al. Intracellular triggering of fas aggregation and recruitment of apoptotic molecules into fas-enriched rafts in selective tumor cell apoptosis. J Exp Med. 2004;200:353–65.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Johnson SM, Robinson R. The composition and fluidity of normal and leukaemic or lymphomatous lymphocyte plasma membranes in mouse and man. Biochim Biophys Acta. 1979;558:282–95.CrossRefPubMed Johnson SM, Robinson R. The composition and fluidity of normal and leukaemic or lymphomatous lymphocyte plasma membranes in mouse and man. Biochim Biophys Acta. 1979;558:282–95.CrossRefPubMed
27.
Zurück zum Zitat Hac-Wydro K, Dynarowicz-Latka P. Effect of edelfosine on tumor and normal cells model membranes—a comparative study. Colloids Surf B: Biointerfaces. 2010;76:366–9.CrossRefPubMed Hac-Wydro K, Dynarowicz-Latka P. Effect of edelfosine on tumor and normal cells model membranes—a comparative study. Colloids Surf B: Biointerfaces. 2010;76:366–9.CrossRefPubMed
28.
Zurück zum Zitat Dynarowicz-Latka P, Hac-Wydro K. Edelfosine in membrane environment—the langmuir monolayer studies. Anti Cancer Agents Med Chem. 2014;14:499–508.CrossRef Dynarowicz-Latka P, Hac-Wydro K. Edelfosine in membrane environment—the langmuir monolayer studies. Anti Cancer Agents Med Chem. 2014;14:499–508.CrossRef
29.
Zurück zum Zitat Gajate C, Mollinedo F. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood. 2007;109:711–9.CrossRefPubMed Gajate C, Mollinedo F. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood. 2007;109:711–9.CrossRefPubMed
30.
Zurück zum Zitat Gajate C, Mollinedo F. The antitumor ether lipid et-18-och(3) induces apoptosis through translocation and capping of fas/cd95 into membrane rafts in human leukemic cells. Blood. 2001;98:3860–3.CrossRefPubMed Gajate C, Mollinedo F. The antitumor ether lipid et-18-och(3) induces apoptosis through translocation and capping of fas/cd95 into membrane rafts in human leukemic cells. Blood. 2001;98:3860–3.CrossRefPubMed
31.
Zurück zum Zitat Gajate C, Santos-Beneit AM, Macho A, Lazaro M, Hernandez-De Rojas A, Modolell M, et al. Involvement of mitochondria and caspase-3 in et-18-och(3)-induced apoptosis of human leukemic cells. Int J Cancer. 2000;86:208–18.CrossRefPubMed Gajate C, Santos-Beneit AM, Macho A, Lazaro M, Hernandez-De Rojas A, Modolell M, et al. Involvement of mitochondria and caspase-3 in et-18-och(3)-induced apoptosis of human leukemic cells. Int J Cancer. 2000;86:208–18.CrossRefPubMed
32.
Zurück zum Zitat Nieto-Miguel T, Fonteriz RI, Vay L, Gajate C, Lopez-Hernandez S, Mollinedo F. Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells. Cancer Res. 2007;67:10368–78.CrossRefPubMed Nieto-Miguel T, Fonteriz RI, Vay L, Gajate C, Lopez-Hernandez S, Mollinedo F. Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells. Cancer Res. 2007;67:10368–78.CrossRefPubMed
33.
Zurück zum Zitat Mollinedo F, Fernandez M, Hornillos V, Delgado J, Amat-Guerri F, Acuna AU, et al. Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria. Cell Death Dis. 2011;2, e158.CrossRefPubMedPubMedCentral Mollinedo F, Fernandez M, Hornillos V, Delgado J, Amat-Guerri F, Acuna AU, et al. Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria. Cell Death Dis. 2011;2, e158.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Shin JN, Park SY, Cha JH, Park JY, Lee BR, Jung SA, et al. Generation of a novel proform of tumor necrosis factor-related apoptosis-inducing ligand (trail) protein that can be reactivated by matrix metalloproteinases. Exp Cell Res. 2006;312:3892–8.CrossRefPubMed Shin JN, Park SY, Cha JH, Park JY, Lee BR, Jung SA, et al. Generation of a novel proform of tumor necrosis factor-related apoptosis-inducing ligand (trail) protein that can be reactivated by matrix metalloproteinases. Exp Cell Res. 2006;312:3892–8.CrossRefPubMed
35.
Zurück zum Zitat Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1:2315–9.CrossRefPubMed Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1:2315–9.CrossRefPubMed
36.
Zurück zum Zitat Berger A, Quast SA, Plotz M, Kammermeier A, Eberle J. Sensitization of melanoma cells for trail-induced apoptosis by bms-345541 correlates with altered phosphorylation and activation of bax. Cell Death Dis. 2013;4, e477.CrossRefPubMedPubMedCentral Berger A, Quast SA, Plotz M, Kammermeier A, Eberle J. Sensitization of melanoma cells for trail-induced apoptosis by bms-345541 correlates with altered phosphorylation and activation of bax. Cell Death Dis. 2013;4, e477.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Quast SA, Berger A, Eberle J. Ros-dependent phosphorylation of bax by wortmannin sensitizes melanoma cells for trail-induced apoptosis. Cell Death Dis. 2013;4, e839.CrossRefPubMedPubMedCentral Quast SA, Berger A, Eberle J. Ros-dependent phosphorylation of bax by wortmannin sensitizes melanoma cells for trail-induced apoptosis. Cell Death Dis. 2013;4, e839.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Yang LQ, Fang DC, Wang RQ, Yang SM. Effect of nf-kappab, survivin, bcl-2 and caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World J Gastroenterol. 2004;10:22–5.PubMedPubMedCentral Yang LQ, Fang DC, Wang RQ, Yang SM. Effect of nf-kappab, survivin, bcl-2 and caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World J Gastroenterol. 2004;10:22–5.PubMedPubMedCentral
39.
Zurück zum Zitat Johnstone RW, Frew AJ, Smyth MJ. The trail apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer. 2008;8:782–98.CrossRefPubMed Johnstone RW, Frew AJ, Smyth MJ. The trail apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer. 2008;8:782–98.CrossRefPubMed
41.
Zurück zum Zitat Kim S, Lee TJ, Leem J, Choi KS, Park JW, Kwon TK. Sanguinarine-induced apoptosis: Generation of ros, down-regulation of bcl-2, c-flip, and synergy with trail. J Cell Biochem. 2008;104:895–907.CrossRefPubMed Kim S, Lee TJ, Leem J, Choi KS, Park JW, Kwon TK. Sanguinarine-induced apoptosis: Generation of ros, down-regulation of bcl-2, c-flip, and synergy with trail. J Cell Biochem. 2008;104:895–907.CrossRefPubMed
42.
Zurück zum Zitat Zhou Y, Tian L, Long L, Quan M, Liu F, Cao J. Casticin potentiates trail-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress. PLoS One. 2013;8, e58855.CrossRefPubMedPubMedCentral Zhou Y, Tian L, Long L, Quan M, Liu F, Cao J. Casticin potentiates trail-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress. PLoS One. 2013;8, e58855.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Kuraoka K, Matsumura S, Sanada Y, Nakachi K, Imai K, Eguchi H, et al. A single nucleotide polymorphism in the extracellular domain of trail receptor dr4 at nucleotide 626 in gastric cancer patients in japan. Oncol Rep. 2005;14:465–70.PubMed Kuraoka K, Matsumura S, Sanada Y, Nakachi K, Imai K, Eguchi H, et al. A single nucleotide polymorphism in the extracellular domain of trail receptor dr4 at nucleotide 626 in gastric cancer patients in japan. Oncol Rep. 2005;14:465–70.PubMed
44.
Zurück zum Zitat Lee KH, Lim SW, Kim HG, Kim DY, Ryu SY, Joo JK, et al. Lack of death receptor 4 (dr4) expression through gene promoter methylation in gastric carcinoma. Langenbeck's Arch Surg / Dtsch Ges Chir. 2009;394:661–70.CrossRef Lee KH, Lim SW, Kim HG, Kim DY, Ryu SY, Joo JK, et al. Lack of death receptor 4 (dr4) expression through gene promoter methylation in gastric carcinoma. Langenbeck's Arch Surg / Dtsch Ges Chir. 2009;394:661–70.CrossRef
45.
Zurück zum Zitat Lacour S, Hammann A, Grazide S, Lagadic-Gossmann D, Athias A, Sergent O, et al. Cisplatin-induced cd95 redistribution into membrane lipid rafts of ht29 human colon cancer cells. Cancer Res. 2004;64:3593–8.CrossRefPubMed Lacour S, Hammann A, Grazide S, Lagadic-Gossmann D, Athias A, Sergent O, et al. Cisplatin-induced cd95 redistribution into membrane lipid rafts of ht29 human colon cancer cells. Cancer Res. 2004;64:3593–8.CrossRefPubMed
46.
Zurück zum Zitat Dimanche-Boitrel MT, Meurette O, Rebillard A, Lacour S. Role of early plasma membrane events in chemotherapy-induced cell death. Drug Resist Updat. 2005;8:5–14.CrossRefPubMed Dimanche-Boitrel MT, Meurette O, Rebillard A, Lacour S. Role of early plasma membrane events in chemotherapy-induced cell death. Drug Resist Updat. 2005;8:5–14.CrossRefPubMed
47.
Zurück zum Zitat Mollinedo F, Gajate C. Fas/cd95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. Drug Resist Updat. 2006;9:51–73.CrossRefPubMed Mollinedo F, Gajate C. Fas/cd95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. Drug Resist Updat. 2006;9:51–73.CrossRefPubMed
48.
Zurück zum Zitat Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev. 2000;1:31–9.CrossRef Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev. 2000;1:31–9.CrossRef
49.
Zurück zum Zitat Gajate C, Gonzalez-Camacho F, Mollinedo F. Involvement of raft aggregates enriched in fas/cd95 death-inducing signaling complex in the antileukemic action of edelfosine in jurkat cells. PLoS One. 2009;4, e5044.CrossRefPubMedPubMedCentral Gajate C, Gonzalez-Camacho F, Mollinedo F. Involvement of raft aggregates enriched in fas/cd95 death-inducing signaling complex in the antileukemic action of edelfosine in jurkat cells. PLoS One. 2009;4, e5044.CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Ono K, Han J. The p38 signal transduction pathway: activation and function. Cell Signal. 2000;12:1–13.CrossRefPubMed Ono K, Han J. The p38 signal transduction pathway: activation and function. Cell Signal. 2000;12:1–13.CrossRefPubMed
51.
Zurück zum Zitat Hsu SC, Gavrilin MA, Tsai MH, Han J, Lai MZ. P38 mitogen-activated protein kinase is involved in fas ligand expression. J Biol Chem. 1999;274:25769–76.CrossRefPubMed Hsu SC, Gavrilin MA, Tsai MH, Han J, Lai MZ. P38 mitogen-activated protein kinase is involved in fas ligand expression. J Biol Chem. 1999;274:25769–76.CrossRefPubMed
52.
Zurück zum Zitat Wang WH, Gregori G, Hullinger RL, Andrisani OM. Sustained activation of p38 mitogen-activated protein kinase and c-jun n-terminal kinase pathways by hepatitis b virus x protein mediates apoptosis via induction of fas/fasl and tumor necrosis factor (tnf) receptor 1/tnf-alpha expression. Mol Cell Biol. 2004;24:10352–65.CrossRefPubMedPubMedCentral Wang WH, Gregori G, Hullinger RL, Andrisani OM. Sustained activation of p38 mitogen-activated protein kinase and c-jun n-terminal kinase pathways by hepatitis b virus x protein mediates apoptosis via induction of fas/fasl and tumor necrosis factor (tnf) receptor 1/tnf-alpha expression. Mol Cell Biol. 2004;24:10352–65.CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat White DE, Burchill SA. Fenretinide-dependent upregulation of death receptors through ask1 and p38alpha enhances death receptor ligand-induced cell death in ewing's sarcoma family of tumours. Br J Cancer. 2010;103:1380–90.CrossRefPubMedPubMedCentral White DE, Burchill SA. Fenretinide-dependent upregulation of death receptors through ask1 and p38alpha enhances death receptor ligand-induced cell death in ewing's sarcoma family of tumours. Br J Cancer. 2010;103:1380–90.CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Ghatan S, Larner S, Kinoshita Y, Hetman M, Patel L, Xia Z, et al. P38 map kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol. 2000;150:335–47.CrossRefPubMedPubMedCentral Ghatan S, Larner S, Kinoshita Y, Hetman M, Patel L, Xia Z, et al. P38 map kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol. 2000;150:335–47.CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat Van Laethem A, Van Kelst S, Lippens S, Declercq W, Vandenabeele P, Janssens S, et al. Activation of p38 mapk is required for bax translocation to mitochondria, cytochrome c release and apoptosis induced by uvb irradiation in human keratinocytes. FASEB J. 2004;18:1946–8.PubMed Van Laethem A, Van Kelst S, Lippens S, Declercq W, Vandenabeele P, Janssens S, et al. Activation of p38 mapk is required for bax translocation to mitochondria, cytochrome c release and apoptosis induced by uvb irradiation in human keratinocytes. FASEB J. 2004;18:1946–8.PubMed
56.
Zurück zum Zitat Choi SY, Kim MJ, Kang CM, Bae S, Cho CK, Soh JW, et al. Activation of bak and bax through c-abl-protein kinase cdelta-p38 mapk signaling in response to ionizing radiation in human non-small cell lung cancer cells. J Biol Chem. 2006;281:7049–59.CrossRefPubMed Choi SY, Kim MJ, Kang CM, Bae S, Cho CK, Soh JW, et al. Activation of bak and bax through c-abl-protein kinase cdelta-p38 mapk signaling in response to ionizing radiation in human non-small cell lung cancer cells. J Biol Chem. 2006;281:7049–59.CrossRefPubMed
57.
Zurück zum Zitat Park GB, Choi Y, Kim YS, Lee HK, Kim D, Hur DY. Ros-mediated jnk/p38-mapk activation regulates bax translocation in sorafenib-induced apoptosis of ebv-transformed b cells. Int J Oncol. 2014;44:977–85.PubMed Park GB, Choi Y, Kim YS, Lee HK, Kim D, Hur DY. Ros-mediated jnk/p38-mapk activation regulates bax translocation in sorafenib-induced apoptosis of ebv-transformed b cells. Int J Oncol. 2014;44:977–85.PubMed
58.
Zurück zum Zitat Farley N, Pedraza-Alva G, Serrano-Gomez D, Nagaleekar V, Aronshtam A, Krahl T, et al. P38 mitogen-activated protein kinase mediates the fas-induced mitochondrial death pathway in cd8+ t cells. Mol Cell Biol. 2006;26:2118–29.CrossRefPubMedPubMedCentral Farley N, Pedraza-Alva G, Serrano-Gomez D, Nagaleekar V, Aronshtam A, Krahl T, et al. P38 mitogen-activated protein kinase mediates the fas-induced mitochondrial death pathway in cd8+ t cells. Mol Cell Biol. 2006;26:2118–29.CrossRefPubMedPubMedCentral
59.
Zurück zum Zitat Zhuang S, Demirs JT, Kochevar IE. P38 mitogen-activated protein kinase mediates bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen but not by hydrogen peroxide. J Biol Chem. 2000;275:25939–48.CrossRefPubMed Zhuang S, Demirs JT, Kochevar IE. P38 mitogen-activated protein kinase mediates bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen but not by hydrogen peroxide. J Biol Chem. 2000;275:25939–48.CrossRefPubMed
Metadaten
Titel
The alkyllysophospholipid edelfosine enhances TRAIL-mediated apoptosis in gastric cancer cells through death receptor 5 and the mitochondrial pathway
verfasst von
Sung-Chul Lim
Keshab Raj Parajuli
Song Iy Han
Publikationsdatum
28.11.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 5/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4485-9

Weitere Artikel der Ausgabe 5/2016

Tumor Biology 5/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.